Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

Toronto Metropolitan University

$359,315.00

A novel approach to treating hemorrhage with mesoporous bioactive glasses.

EF 2015-16

Résumé
Hemorrhage is the most common cause of mortality during both surgery and trauma. Mesoporous bioactive glasses (MBGs) have the potential to act as hemostatic agents as their high specific surface area can accelerate blood clotting when applied to a wound. We will build on our preliminary work in this space by synthesizing a range of anti-bacterial, anti-inflammatory MBGs and incorporating them into cellulose gauze. These materials could decrease hemorrhage deaths and become an invaluable tool in both the surgical field and on-board first responder vehicles.
Programme
Project Grant
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
346589
Name
Towler Mark R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
A novel approach to treating hemorrhage with mesoporous bioactive glasses.
Programtype2
Operating Grants
Orgnameinp2
Toronto Metropolitan University
Cihramount2
$359,315
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Bioactivity; Hemorrhage; Mesoporous Glass
Abstract
Hemorrhage is the most common cause of mortality during both surgery and trauma. Mesoporous bioactive glasses (MBGs) have the potential to act as hemostatic agents as their high specific surface area can accelerate blood clotting when applied to a wound. We will build on our preliminary work in this space by synthesizing a range of anti-bacterial, anti-inflammatory MBGs and incorporating them into cellulose gauze. These materials could decrease hemorrhage deaths and become an invaluable tool in both the surgical field and on-board first responder vehicles.
Competitiondate
201603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Towler, Mark R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $359,315~ $0~